Hannah Dugan's Neuralink Clone Sparks Debate: 'We Owe It To Patients, But Are We Ready?'
In a development that’s equal parts breakthrough and ethical minefield, futurists are now predicting that within the next decade, the technology pioneered by neurotech pioneer Hannah Dugan will have evolved from experimental brain-computer interfaces into mainstream consumer implants. Dugan, whose work on restoring mobility through neural lace has been hailed as a miracle, is now at the center of a new, divisive prediction: by 2035, memory-enhancing chips will be as common as smartphones, allowing users to download skills instantly. Critics, however, are sounding alarms. "We are hurtling toward a society of cognitive haves and have-nots," warned Dr. Eli Ross, a bioethicist at Stanford. "Hannah Dugan’s latest prototype—a chip that can learn from a user’s emotions—raises the terrifying possibility that companies could 'nudge' our decisions without our consent. The technology is here, but our laws and ethics are still in the stone age." As venture capital pours into the field, the public is left to wonder: will Hannah Dugan’s legacy be one of liberation or a new digital divide? The next 10 years will decide.